目前在发现针对玛雅罗热的治疗方法方面存在挑战
Rafael Elias Marques1, Jacqueline Farinha Shimizu1, Maurício Lacerda Nogueira2,3
1Brazilian Biosciences National Laboratory - LNBio, Brazilian Center for Research in Energy and Materials - CNPEM, Campinas, São Paulo, Brazil.
Expert opinion on therapeutic targets
|May 7, 2024
概括
玛雅罗病毒 (MAYV) 感染导致发烧和持续的关节疼痛. 目前的研究审查了潜在的治疗方法,强调了需要更好的实验模型来推进这种新兴疾病的药物开发.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 玛雅罗热是一种新兴的病毒性疾病,导致急性发烧和慢性关节痛.
- 没有特殊的治疗方法,导致严重的公共卫生和社会经济负担.
- 玛雅罗病毒 (MAYV) 是一种阿尔法病毒,对其特定的生物学和发病因子的研究有限.
研究的目的:
- 审查针对玛雅罗病毒感染的候选治疗方法.
- 评估查技术和实验模型,以评估潜在的治疗方法.
- 确定开发有效MAYV治疗方法的挑战和机遇.
主要方法:
- 关于玛雅罗病毒治疗研究的综合文献综述.
- 对针对病毒或宿主机制的抗病毒化合物的分析.
- 对实验模型和复合选技术的评估.
主要成果:
- 几种抗病毒化合物显示出前景,主要通过体外研究证明.
- 由于实验模型不足,化合物在体内或临床前研究的进展有限.
- 针对炎症反应的治疗策略显示出减少玛雅罗病毒疾病后果的潜力.
结论:
- 尽管已经确定了候选治疗方法,但在梅亚罗病毒的临床前和体内验证中存在重大差距.
- 实验模型的进步对于成功开发有效的玛雅罗病毒疗法至关重要.
- 针对炎症途径提供了一个有前途的途径,用于管理玛雅罗病毒引起的疾病及其长期影响.
相关概念视频
Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


